----

----

| [      x ] | Quarterly      Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of      1934 for the Quarterly Period Ended March 31,  2009 |
|------------|--------------------------------------------------------------------------------------------------------------------------------------------------|

|   | or |
|--------|----|

| [    ] | Transition      Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of      1934 for the Transition Period    from    to |
|----------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Atrion      Corporation                                     |
|-------------------------------------------------------------|
| (Exact      Name of Registrant as Specified in its Charter) |
|                                                        |   |   |
| Delaware                                                    |   | 63-0821819 |
| (State      or Other Jurisdiction of                        |   | (I.R.S.      Employer Identification No.) |
|        Incorporation or Organization)                  |   |        Identification No.) |
|                                                        |        One Allentown Parkway, Allen,      Texas  75002 |   |
|                                                        |  (Address      of Principal Executive Offices)   (ZipCode) |   |
|                                                        |   |   |
|                                                        |   |   |
|                                                        |  (972) 390-9800 |   |
|                                                        |  (Registrant’s      Telephone Number, Including Area Code) |   |

xYes
 o No

 o            Acceleratedfiler 
 x                               Non-acceleratedfiler 
 o                                         Smallerreporting company  o

   Yes
  o       No  x

|  Title      of Each Class               |   | Number      of Shares Outstanding atApril      27, 2009 |
|----------------------------------------------|--------|---------------------------------------------------------|
| Common      stock, Par Value $0.10 per share |   | 1,979,171                                               |

----

|  PART I.   Financial Information |   2 |
|------------------------------------------------------|---------------|
|                                                 |          |

|    Item 1.        Financial Statements                                                                                                                                                                          |   |          |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|---------------|
|                                                                                                                                                                                                                                |   |          |
|                                  Consolidated Statements of Income    (Unaudited)            |   |          |
|                                   For the Three months Ended                            |   |          |
|                                   March 31, 2009 and 2008                               |   |   3 |
|                                                                                                                                                                                                                                |   |          |
|                                                                                                                                                                                                                                |   |          |
|                                  Consolidated Balance Sheets (Unaudited)                     |   |          |
|                                    March 31, 2009 and December 31, 2008            |   |   4 |
|                                                                                                                                                                                                                                |   |          |
|                                                                                                                                                                                                                                |   |          |
|                                  Consolidated Statements of Cash Flows      (Unaudited)      |   |          |
|                                   For the Three months Ended                            |   |          |
|                                   March 31, 2009 and 2008                               |   |   5 |
|                                                                                                                                                                                                                                |   |          |
|                                                                                                                                                                                                                                |   |          |
|                                  Notes to Consolidated Financial Statements      (Unaudited) |   |   6 |
|                                                                                                                                                                                                                                |   |          |
|                                                                                                                                                                                                                           |   |          |
|    Item      2.         Management's Discussion and Analysis of                                                                                                              |   |          |
|                                Financial Condition and Results of                                      |   |          |
|                                Operations                                                              |   |  10      |
|                                                                                                                                                                                                                                |   |          |
|    Item      3.         Quantitative and Qualitative Disclosures About Market      Risk                                                                                      |   |  14      |
|                                                                                                                                                                                                                                |   |          |
|    Item      4.         Controls and Procedures                                                                                                                              |   |  14      |
|                                                                                                                                                                                                                                |   |          |
|  PART      II.  Other Information                                                                                                                                                                                         |   |  15      |
|                                                                                                                                                                                                                                |   |          |
|    Item      1.         Legal Proceedings                                                                                                                                    |   |  15      |
|                                                                                                                                                                                                                                |   |          |
|    Item      1A.      Risk      Factors                                                                                                                                                     |   |  15      |
|                                                                                                                                                                                                                                |   |          |
|    Item      2.         Unregistered Sales of Equity Securities and Use of      Proceeds                                                                                     |   |  15      |
|                                                                                                                                                                                                                                |   |          |
|    Item      6.         Exhibits                                                                                                                                                  |   |  16      |
|                                                                                                                                                                                                                                |   |          |

|  SIGNATURES |   |  17 |
|------------------|--------|----------|

----

A

----

N 

|                                             |   | Three      Months EndedMarch      31,         |   |
|--------------------------------------------------|--------|-----------------------------------------------|--------|
|                                             |   | 2009                                          |   |   | 2008 |   |
|                                             |   | (in      thousands, except per share amounts) |   |
| Revenues                                         |   | $                                             | 25,047 |   |   | $ | 24,602 |   |
| Cost      of goods sold                          |   |                                          | 13,958 |   |   |   | 13,922 |   |
| Gross      profit                                |   |                                          | 11,089 |   |   |   | 10,680 |   |
| Operating      expenses:                         |   |                                          |   |   |   |   |   |   |
| Selling                                          |   |                                          | 1,493  |   |   |   | 1,699 |   |
| General      and administrative                  |   |                                          | 2,717  |   |   |   | 2,740 |   |
| Research      and development                    |   |                                          | 770    |   |   |   | 787 |   |
|                                             |   |                                          | 4,980  |   |   |   | 5,226 |   |
|                                             |   |                                          |   |   |   |   |   |   |
| Operating      income                            |   |                                          | 6,109  |   |   |   | 5,454 |   |
| Other      income:                               |   |                                          |   |   |   |   |   |   |
| Interest      income                             |   |                                          | 102    |   |   |   | 36 |   |
|                                             |   |                                          | 102    |   |   |   | 36 |   |
| Income      before provision for income taxes    |   |                                          | 6,211  |   |   |   | 5,490 |   |
| Provision      for income taxes                  |   |                                          | (2,077 | ) |   |   | (1,834 | ) |
|                                             |   |                                          |   |   |   |   |   |   |
| Net      income                                  |   | $                                             | 4,134  |   |   | $ | 3,656 |   |
|                                             |   |                                          |   |   |   |   |   |   |
| Income      per basic share                      |   | $                                             | 2.09   |   |   | $ | 1.88 |   |
| Weighted      average basic shares outstanding   |   |                                          | 1,974  |   |   |   | 1,943 |   |
|                                             |   |                                          |   |   |   |   |   |   |
| Income      per diluted share                    |   | $                                             | 2.06   |   |   | $ | 1.83 |   |
| Weighted      average diluted shares outstanding |   |                                          | 2,003  |   |   |   | 2,003 |   |
|                                             |   |                                          |   |   |   |   |   |   |
| Dividends      per common share                  |   | $                                             | 0.30   |   |   | $ | 0.24 |   |
|                                             |   |                                          |   |   |   |   |   |   |

----

R

|                                                             |   | March      31,      |    |    | December      31, |   |
|------------------------------------------------------------------|--------|---------------------|---------|---------|-------------------|--------|
|  Assets                                                     |   | 2009                |    |    | 2008              |   |
|                                                             |   | (in      thousands) |    |
| Current      assets:                                             |   |                |    |    |              |   |
|        Cash and cash equivalents                            |   | $                   | 16,731  |    |              | $      | 12,056 |   |
|        Short-term investments                               |   |                | 4,657   |    |              |   | 4,692 |   |
|        Accounts receivable                                  |   |                | 13,249  |    |              |   | 10,875 |   |
|        Inventories                                          |   |                | 19,459  |    |              |   | 20,169 |   |
|        Prepaid expenses                                     |   |                | 644     |    |              |   | 719 |   |
|        Deferred income taxes                                |   |                | 596     |    |              |   | 596 |   |
|                                                             |   |                | 55,336  |    |              |   | 49,107 |   |
|                                                             |   |                |    |    |              |   |   |   |
|                                                             |   |                |    |    |              |   |   |   |
| Property,      plant and equipment                               |   |                | 95,328  |    |              |   | 94,364 |   |
| Less      accumulated depreciation and amortization              |   |                | 42,307  |    |              |   | 40,994 |   |
|                                                             |   |                | 53,021  |    |              |   | 53,370 |   |
|                                                             |   |                |    |    |              |   |   |   |
| Other      assets and deferred charges:                          |   |                |    |    |              |   |   |   |
|        Patents                                              |   |                | 1,790   |    |              |   | 1,863 |   |
|        Goodwill                                             |   |                | 9,730   |    |              |   | 9,730 |   |
|        Other                                                |   |                | 1,273   |    |              |   | 1,283 |   |
|                                                             |   |                | 12,793  |    |              |   | 12,876 |   |
|                                                             |   |                |    |    |              |   |   |   |
|                                                             |   | $                   | 121,150 |    |              | $      | 115,353 |   |
|                                                             |   |                |    |    |              |   |   |   |
|                                                             |   |                |    |    |              |   |   |   |
|                                                             |   |                |    |    |              |   |   |   |
| Liabilities and Stockholders’      Equity                  |   |                |    |    |              |   |   |   |
| Current      liabilities:                                        |   |                |    |    |              |   |   |   |
|        Accounts payable and accrued liabilities             |   | $                   | 5,720   |    |              | $      | 5,482 |   |
|        Accrued income and other taxes                       |   |                | 1,953   |    |              |   | 731 |   |
|                                                             |   |                | 7,673   |    |              |   | 6,213 |   |
|                                                             |   |                |    |    |              |   |   |   |
| Line      of credit                                              |   |                | --      |    |              |   | -- |   |
|                                                             |   |                |    |    |              |   |   |   |
| Other      non-current liabilities                               |   |                | 8,475   |    |              |   | 8,298 |   |
|                                                             |   |                |    |    |              |   |   |   |
| Stockholders’      equity:                                 |   |                |    |    |              |   |   |   |
|        Common shares, par value $0.10 per share; authorized |   |                |    |    |              |
|         10,000 shares, issued 3,420 shares             |   |                | 342     |    |              |   | 342 |   |
|        Paid-in capital                                      |   |                | 19,824  |    |              |   | 19,130 |   |
|        Accumulated other comprehensive loss                 |   |                | (533    | )  |              |   | (533 | )  |
|        Retained earnings                                    |   |                | 121,091 |    |              |   | 117,554 |   |
|        Treasury shares,1,441 at March 31, 2009 and 1,452    |   |                |    |    |              |
|         at December 31, 2008, at cost                  |   |                | (35,722 | )  |              |   | (35,651 | )  |
|          Total stockholders’ equity         |   |                | 105,002 |    |              |   | 100,842 |   |
|                                                             |   |                |    |    |              |   |   |   |
|                                                             |   |                |    |    |              |   |   |   |
|                                                             |   | $                   | 121,150 |    |              | $      | 115,353 |   |
|                                                             |   |                |    |    |              |   |   |   |

----

A

|                                                                                               |   |  Three      months Ended |   |
|----------------------------------------------------------------------------------------------------|--------|-------------------------------|--------|
|                                                                                               |   |  March 31,               |   |
|                                                                                               |   | 2009                          |   |   | 2008 |   |
|                                                                                               |   |  (In      thousands)     |   |
| Cash      flows from operating activities:                                                         |   |                          |   |   |
|        Net income                                                                             |   | $                             | 4,134  |   |   | $ | 3,656 |   |
|        Adjustments to reconcile net income to                                                 |   |                          |   |   |   |
|         net cash provided by operating activities:                                       |   |                          |   |   |   |
|          Depreciation and amortization                                              |   |                          | 1,597  |   |   |   | 1,497 |   |
|          Deferred income taxes                                                      |   |                          | 153    |   |   |   | 134 |   |
|          Stock-based compensation                                                   |   |                          | 165    |   |   |   | 113 |   |
|          Other                                                                      |   |                          | --     |   |   |   | 37 |   |
|                                                                                               |   |                          | 6,049  |   |   |   | 5,437 |   |
|                                                                                               |   |                          |   |   |   |   |   |   |
|        Changes in operating assets and liabilities:                                           |   |                          |   |   |   |
|          Accounts receivable                                                        |   |                          | (2,374 | )  |   |   | (2,668) |   |
|          Inventories                                                                |   |                          | 710    |   |   |   | (590) |   |
|          Prepaid expenses                                                           |   |                          | 75     |   |   |   | 789 |   |
|          Other non-current assets                                                   |   |                          | 10     |   |   |   | (43 | )  |
|          Accounts payable and accrued liabilities                                   |   |                          | 238    |   |   |   | 1,232 |   |
|          Accrued income and other taxes                                             |   |                          | 1,222  |   |   |   | (486 | )  |
|          Other non-current liabilities                                              |   |                          | 24     |   |   |   | (124 | )  |
|                                                                                               |   |                          | 5,954  |   |   |   | 3,547 |   |
|                                                                                               |   |                          |   |   |   |   |   |   |
| Cash      flows from investing activities:                                                         |   |                          |   |   |   |
|        Property, plant and equipment additions                                                |   |                          | (1,175 | )  |   |   | (2,357 | )  |
|        Investments                                                                            |   |                          | 35     |   |   |   | -- |   |
|                                                                                               |   |                          | (1,140 | )  |   |   | (2,357 | )  |
|                                                                                               |   |                          |   |   |   |   |   |   |
| Cash      flows from financing activities:                                                         |   |                          |   |   |   |
|        Exercise of stock options                                                              |   |                          | 445    |   |   |   | 497 |   |
|        Shares tendered for employees’ taxes on      stock-based  compensation |   |                          | (70    | )  |   |   | (870 | )  |
|        Tax benefit related to stock options                                                   |   |                          | 80     |   |   |   | 1,393 |   |
|   Dividends      paid                                                                    |   |                          | (594   | )  |   |   | (471 | )  |
|                                                                                               |   |                          | (139   | ) |   |   | 549 |   |
|                                                                                               |   |                          |   |   |   |   |   |   |
| Net      change in cash and cash equivalents                                                       |   |                          | 4,675  |   |   |   | 1,739 |   |
| Cash      and cash equivalents at beginning of period                                              |   |                          | 12,056 |   |   |   | 3,531 |   |
| Cash      and cash equivalents at end of period                                                    |   | $                             | 16,731 |   |   | $ | 5,270 |   |
|                                                                                               |   |                          |   |   |   |   |   |   |
|                                                                                               |   |                          |   |   |   |   |   |   |
|                                                                                               |   |                          |   |   |   |   |   |   |
| Cash      paid for:                                                                                |   |                          |   |   |   |   |   |   |
|        Income taxes                                                                           |   | $                             | 498    |   |   | $ | 64 |   |

----

|   | ATRION      CORPORATION AND SUBSIDIARIES |
|--------|------------------------------------------|

|   | NOTES TO CONSOLIDATED FINANCIAL STATEMENTS |
|--------|--------------------------------------------|

|   | (Unaudited) |
|--------|-------------|

|                   |   | March      31, |   |   | December      31, |   |
|------------------------|--------|----------------|--------|--------|-------------------|--------|
|                   |   | 2009           |   |   | 2008              |   |
| Raw      materials     |   | $              | 8,246  |   |              | $      | 8,978 |   |
| Work      in process   |   |           | 4,880  |   |              |   | 4,579 |   |
| Finished      goods    |   |           | 6,333  |   |              |   | 6,612 |   |
| Total      inventories |   | $              | 19,459 |   |              | $      | 20,169 |   |

|                                               |   | Three      months ended March 31,             |   |
|----------------------------------------------------|--------|-----------------------------------------------|--------|
|                                               |   | 2009                                          |   |   | 2008 |   |
|                                               |   | (in      thousands, except per share amounts) |   |
| Net      income                                    |   | $                                             | 4,134  |   |   | $ | 3,656 |   |
|                                               |   |                                          |   |   |   |   |   |   |
| Weighted      average basic shares outstanding     |   |                                          | 1,974  |   |   |   | 1,943 |   |
| Add:  Effect      of dilutive securities |   |                                          | 29     |   |   |   | 60 |   |
| Weighted      average diluted shares outstanding   |   |                                          | 2,003  |   |   |   | 2,003 |   |

| Earnings      per share: |   |   |   |   |   |   |
|--------------------------|--------|--------|--------|--------|--------|--------|
| Basic                    |   | $      | 2.09   |   |   | $      | 1.88 |   |
| Diluted                  |   | $      | 2.06   |   |   | $      | 1.83 |   |

----

----

|   | ATRION      CORPORATION AND SUBSIDIARIES |
|--------|------------------------------------------|

|   | NOTES      TO CONSOLIDATED FINANCIAL STATEMENTS |
|--------|-------------------------------------------------|

|   | (Unaudited) |
|--------|-------------|

|                                                    |   |   |   |   | Gross      Unrealized |   |    |   |   |
|---------------------------------------------------------|--------|--------|--------|--------|-----------------------|--------|---------|--------|--------|
|                                                    |   | Cost   |   |   | Gains                 |   |    | Losses |   |   | Fair      value |   |
| Corporate      bonds                                    |   | $      | 4,020  |   |                  |   | — |   |   | $ | (34 | ) |   | $ | 3,986 |   |
|  Municipal      tax-exempt bond                    |   |   | 637    |   |                  |   | — |   |   |   | (5 | ) |   |   | 632 |   |
|                                                    |   |   |   |   |                  |   |    |   |   |   |   |   |   |   |   |   |
|  Total      investment securities held to maturity |   | $      | 4,657  |   |                  |   | — |   |   | $ | (39 | ) |   | $ | 4,618 |   |
|                                                    |   |   |   |   |                  |   |    |   |   |   |   |   |   |   |   |   |

| (5)   | Pension      Benefits |
|-----------------|-----------------------|

|                                 |   | Three      Months ended March 31, |   |
|--------------------------------------|--------|----------------------------------------|--------|
|                                 |   | 2009                                   |   |   | 2008 |   |
| Service      cost                    |   | $                                      | --     |   |   | $ | -- |   |
| Interest      cost                   |   |                                   | 54     |   |   |   | 56 |   |
| Expected      return on assets       |   |                                   | (54    | ) |   |   | (55 | ) |
| Prior      service cost amortization |   |                                   | --     |   |   |   | -- |   |
| Actuarial      loss                  |   |                                   | 8      |   |   |   | 8 |   |
|                                 |   |                                   |   |   |   |   |   |   |
| Net      periodic pension cost       |   | $                                      | 8      |   |   | $ | 9 |   |

----

| (6)   | Recent      Accounting Pronouncements |
|-----------------|---------------------------------------|

----

| Item      2. | Management’s      Discussion and Analysis of Financial Condition and Results      of Operations |
|--------------|-------------------------------------------------------------------------------------------------------|

| ·   |  Focusing      on customer needs;                                                    |
|--------------------|-------------------------------------------------------------------------------------------|
| ·   |  Expanding      existing product lines and developing new products;                  |
| ·   |  Maintaining      a culture of controlling cost; and                                 |
| ·   | Preserving      and fostering a collaborative, entrepreneurial management      structure. |

----

|                |   | Three      Months endedMarch      31, |   |
|---------------------|--------|---------------------------------------|--------|
|                |   | 2009                                  |   |   | 2008 |   |
|                |   |                                  |   |   |   |   |
| Fluid      Delivery |   | $                                     | 8,656  |   |   | $ | 8,249 |   |
| Cardiovascular      |   |                                  | 7,211  |   |   |   | 7,467 |   |
| Ophthalmology       |   |                                  | 4,935  |   |   |   | 3,779 |   |
| Other               |   |                                  | 4,245  |   |   |   | 5,107 |   |
| Total               |   | $                                     | 25,047 |   |   | $ | 24,602 |   |

----

----

----

| Item 3. | Quantitative      and Qualitative Disclosures About Market Risk |
|---------|-----------------------------------------------------------------|

| Item      4. | Controls      and Procedures |
|--------------|------------------------------|

----

A

| Period                          | Total      Number of Shares Purchased | Average      Price Paid per Share                                                                                                                                                                   | Total      Number of Shares Purchased as Part of Publicly Announced Plans or      Programs | Maximum      Number of Shares that May  Yet Be Purchased Under the Plans or      Programs (1) |
|---------------------------------|---------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------|
| 1/1/2009      through 1/31/2009 |  --                              |                                       -- | --                                                                                         |  68,100                                                                                                 |
| 2/1/2009      through 2/28/2009 |  1,704(2)                        |  $                                78.06                      | --                                                                                         |  68,100                                                                                                 |
| 3/1/2009      through 3/31/2009 |  --                              |                 --                                                                                                                                | --                                                                                         |  68,100                                                                                                 |
| Total                           | 1,704                                 | $                                78.06                            | --                                                                                         | 68,100                                                                                                       |

| (1)   | The      Company has a program that was announced in April 2000 to purchase in open      market or privately negotiated transactions up to 200,000 shares. The      program has no expiration date but may be terminated at any time by the      Board of Directors. |
|-----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2)   | Consists      of shares delivered to the Company in payment of the exercise price of      options exercised by a participant in a Company equity incentive plan. The      Company’s equity incentive plans permit a participant under certain      circumstances to deliver shares of Company stock in payment of the      exercise price of optionsexercised. |
|-----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   |  Exhibit    |                                                                                                                                           |
|--------|------------------|------------------------------------------------------------------------------------------------------------------------------------------------|
|   |  Number     |              Description                                                                                    |
|   |             |                                                                                                                                           |
|   |  10.1       |  Change in      Control Agreement for President and Chief Operating Officer                                                               |
|   |             |                                                                                                                                           |
|   |  31.1       |  Sarbanes-Oxley      Act Section 302 Certification of Chief Executive Officer                                                             |
|   |             |                                                                                                                                           |
|   |  31.2       |  Sarbanes-Oxley      Act Section 302 Certification of Chief Financial Officer                                                             |
|   |             |                                                                                                                                           |
|   |  32.1       |  Certification      Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section 906 of      The Sarbanes – Oxley Act Of 2002 |
|   |             |                                                                                                                                           |
|   |  32.2  |  Certification      Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section 906 of      The Sarbanes – Oxley Act Of 2002 |
|   |             |                                                                                                                                           |
|   |             |                                                                                                                                           |

----

|                                                |  Atrion Corporation                                                                                                                        |
|-----------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                |  (Registrant)                                                                                                                              |
|                                                |                                                                                                                                            |
|                                                |                                                                                                                                            |
|  Date:  May      8, 2009        |  By:             /s/ Emile A.      Battat                                 |
|                                                |                          Emile A. Battat         |
|                                                |                          Chairman and            |
|                                                |                          Chief Executive Officer |
|                                                |                                                                                                                                            |
|                                                |                                                                                                                                            |
|  Date:  May      8, 2009   |  By:             /s/ Jeffery      Strickland                              |
|                                                |                     Jeffery      Strickland |
|                                                |                          Vice President and      |
|                                                |                          Chief Financial Officer |
|                                                |                                                                                                                                            |
|                                                |                                                                                                                                            |
|                                                |                                                                                                                                            |

----

----